(SCHK) Schwab 1000 - Overview
Etf: Large-Cap, Mid-Cap, Blend, Equity, Diversified
Dividends
| Dividend Yield | 1.18% |
| Yield on Cost 5y | 1.95% |
| Yield CAGR 5y | -9.93% |
| Payout Consistency | 93.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.1% |
| Relative Tail Risk | 4.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | -0.35 |
| Character TTM | |
|---|---|
| Beta | 0.975 |
| Beta Downside | 0.978 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.20% |
| CAGR/Max DD | 1.08 |
Description: SCHK Schwab 1000 January 10, 2026
The Schwab 1000 Index (NYSE ARCA: SCHK) tracks the 1,000 largest U.S. equities by float-adjusted market capitalization, using a market-cap weighted methodology. The ETF is required to hold at least 90 % of its net assets-including any investment-purpose borrowings-in the index constituents.
Key data (as of Q4 2025): expense ratio 0.04 %, total assets ≈ $12 billion, and average daily trading volume ≈ 1.8 million shares. The fund’s sector exposure mirrors the broad market: ≈ 40 % in technology, 20 % in financials, and 15 % in health care, making it a proxy for large-blend performance.
Economic drivers that tend to move SCHK include U.S. GDP growth and corporate earnings trends, as the index is heavily weighted toward cyclical sectors. A rising Fed policy rate typically compresses valuations for the high-beta tech component, while a strengthening dollar can affect multinational earnings and thus the index’s overall return.
Because SCHK mirrors the top-tier of U.S. market cap, its performance historically tracks the S&P 500 with a correlation of about 0.97, but it offers slightly higher exposure to the mega-cap segment, which can amplify gains in a bull market.
For a deeper dive into the fund’s risk-adjusted returns and sector tilt, you might explore ValueRay’s analytical tools to see how SCHK fits into a diversified portfolio.
What is the price of SCHK shares?
Over the past week, the price has changed by +0.06%, over one month by -0.24%, over three months by +3.47% and over the past year by +14.69%.
Is SCHK a buy, sell or hold?
What are the forecasts/targets for the SCHK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 39 | 17.1% |
SCHK Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.96b USD (4.96b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 4.96b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 4.96b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.51% (E(4.96b)/V(4.96b) * Re(9.51%) + (debt-free company))
Discount Rate = 9.51% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)